Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income	$ 11,786	$ 3,976,791
Adjustments to reconcile net income to net cash used in operating activities:
Interest income earned	(109,190)	(8,287)
Change in fair value of warrant liabilities	(278,719)	(4,326,744)
Changes in current assets and liabilities:
Prepaid expenses	88,660	55,103
Other current liability - Advance from target	250,000
Due to sponsor		(10,000)
Accrued offering costs and expenses	8,845	(85,314)
Income taxes payable	16,420
Net cash used in operating activities	(12,198)	(398,451)
Cash flows from investing activities:
Investment of cash in Trust Account	80,422
Net cash provided by investing activities	80,422
Cash flows from financing activities:
Proceeds from advance from target for extension notes	(250,000)
Proceeds from working capital loans - related party		337,000
Net cash (used in) provided by financing activities	(250,000)	337,000
Net change in cash	(181,776)	(61,451)
Cash – Beginning of the period	407,250	264,755
Cash – End of the period	225,474	203,304
Supplemental disclosure of non-cash financing activities:
Accretion of Class A common stock subject to possible redemption	$ (375,898)